title: Dyslipidemia awareness, treatment, control and influence factors among adults in the Jilin province in China: a cross-sectional study.
abstract: BACKGROUND
  In China, even though the prevalence of dyslipidemia among adults increased yearly and dyslipidemia being an important risk factor for cardiovascular diseases among the Chinese population, however, the awareness, treatment and control of dyslipidemia are at low levels, and only limited studies on the influence factors associated with the awareness, treatment and control dyslipidemia in China have been carried out.
  
  
  METHODS
  The analysis was based on a representative sample of 7138 adult subjects aged 18~79 years recruited from a cross-sectional study of chronic disease and risk factors among adults in the Jilin province in 2012. Chi-square test was used to compare the rates of dyslipidemia awareness, treatment and control between different characteristics of participants. Multiple logistic regression analyses were performed separately for each group to explore the associations between participants' characteristics and dyslipidemia awareness, treatment and control.
  
  
  RESULTS
  Among participants with dyslipidemia, 11.6% were aware of the diagnosis, 8.4% were receiving treatment, and 34.8% had dyslipidemia controlled. Increase in age and BMI ≥ 24 kg/m2 were by far the strongest risk factors associated with better awareness and treatment of dyslipidemia. Retirees were more likely to be aware of their dyslipidemia condition (OR=1.255; 95% CI: 1.046, 1.506) and to be receiving treatment (OR=1.367; 95% CI: 1.114, 1.676) than manual workers. A family history of dyslipidemia increased the likelihood of awareness (OR=3.620; 95% CI: 2.816, 4.653) and treatment (OR=3.298; 95% CI: 2.488, 4.371) of dyslipidemia. Alcohol drinking and physical activity were associated with a lower level of awareness and treatment.Cigarette smokers (OR=0.501; 95% CI: 0.349, 0.719) and those with BMI ≥ 24 kg/m2 (OR=0.480; 95% CI: 0.326, 0.706) who received treatment were also associated with poor dyslipidemia control.
  
  
  CONCLUSIONS
  Our study highlights low levels of awareness, poor treatment and control of dyslipidemia among adults aged 18~79 in the Jilin province. Promotion of healthy lifestyles and establishment of a comprehensive strategy of screening, treatment and control of dyslipidemia is needed to reduce or prevent the risk of cardiovascular disease in the Jilin province.
authors.forename: Huan
authors.initials: H
authors.lastname: He
authors.forename: Ya-qin
authors.initials: YQ
authors.lastname: Yu
authors.forename: Yong
authors.initials: Y
authors.lastname: Li
authors.forename: Chang-gui
authors.initials: CG
authors.lastname: Kou
authors.forename: Bo
authors.initials: B
authors.lastname: Li
authors.forename: Yu-chun
authors.initials: YC
authors.lastname: Tao
authors.forename: Qing
authors.initials: Q
authors.lastname: Zhen
authors.forename: Chang
authors.initials: C
authors.lastname: Wang
authors.forename: Joseph Sam
authors.initials: JS
authors.lastname: Kanu
authors.forename: Xu-feng
authors.initials: XF
authors.lastname: Huang
authors.forename: Mei
authors.initials: M
authors.lastname: Han
authors.affiliation: Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun 130021, China. ywliu@jlu.edu.cn.
authors.forename: Ya-wen
authors.initials: YW
authors.lastname: Liu
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002681:China / Q000453:epidemiology; D003430:Cross-Sectional Studies; D050171:Dyslipidemias / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008297:Male; D008875:Middle Aged; D050177:Overweight / Q000150:complications / Q000453:epidemiology; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects / Q000453:epidemiology; D055815:Young Adult
references.citation: Zhonghua Xin Xue Guan Bing Za Zhi. 2010 Jun;38(6):562-6
references.pmid: 21033142
references.citation: Circulation. 2004 Jul 27;110(4):405-11
references.pmid: 15238453
references.citation: Prev Chronic Dis. 2010 May;7(3):A61
references.pmid: 20394700
references.citation: J Gerontol A Biol Sci Med Sci. 2009 Feb;64(2):256-63
references.pmid: 19181717
references.citation: High Alt Med Biol. 2012 Mar;13(1):13-21
references.pmid: 22429228
references.citation: J Hum Hypertens. 2006 Nov;20(11):874-81
references.pmid: 16929341
references.citation: Lipids Health Dis. 2014 Jan 06;13:4
references.pmid: 24393232
references.citation: J Atheroscler Thromb. 2012;19(2):159-68
references.pmid: 22041495
references.citation: Zhonghua Yu Fang Yi Xue Za Zhi. 2005 Sep;39(5):306-10
references.pmid: 16266538
references.citation: PLoS One. 2011 Mar 10;6(3):e17326
references.pmid: 21423741
references.citation: Circulation. 2006 Feb 7;113(5):647-56
references.pmid: 16461837
references.citation: Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Jul;26(7):478-84
references.pmid: 16334996
references.citation: Zhonghua Liu Xing Bing Xue Za Zhi. 2005 Feb;26(2):77-83
references.pmid: 15921604
references.citation: Arq Bras Cardiol. 2008 Jan;90(1):24-30
references.pmid: 18317637
references.citation: Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Jul;46(7):607-12
references.pmid: 22943915
references.citation: Med J Aust. 2010 Feb 1;192(3):127-32
references.pmid: 20121678
references.citation: Prev Med. 2003 Apr;36(4):398-402
references.pmid: 12649047
references.citation: PLoS One. 2013;8(3):e57920
references.pmid: 23483942
references.citation: Zhonghua Yu Fang Yi Xue Za Zhi. 2012 Aug;46(8):687-91
references.pmid: 23157860